ICU Medical, Inc. (ICUI)

ICU Medical Stock Forecast

Stock Price Forecast

The 4 analysts that cover ICU Medical stock have a consensus rating of "Strong Buy" and an average price target of $178.5, which forecasts a 36.66% increase in the stock price over the next year. The lowest target is $163 and the highest is $191.

Price Target: $178.5 (+36.66%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$163	$178.5	$180	$191
Change	+24.79%	+36.66%	+37.80%	+46.23%

Analyst Ratings

The average analyst rating for ICU Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26
Strong Buy	2	2	2	1	1	1
Buy	3	3	3	3	3	3
Hold	1	1	1	1	1	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	6	6	6	5	5	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jason Bednar Piper Sandler	Piper Sandler	Buy Maintains $178 → $163	Buy	Maintains	$178 → $163	+24.79%	Apr 17, 2026
Brett Fishbin Keybanc	Keybanc	Buy Maintains $175 → $180	Buy	Maintains	$175 → $180	+37.80%	Feb 20, 2026
Jason Bednar Piper Sandler	Piper Sandler	Buy Maintains $172 → $178	Buy	Maintains	$172 → $178	+36.27%	Feb 20, 2026
Brett Fishbin Keybanc	Keybanc	Buy Maintains $173 → $175	Buy	Maintains	$173 → $175	+33.98%	Nov 7, 2025
Jason Bednar Piper Sandler	Piper Sandler	Buy Maintains $153 → $172	Buy	Maintains	$153 → $172	+31.68%	Nov 7, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

2.22B

Decreased by -0.50%

from 2.23B

Revenue Next Year

2.32B

Increased by 4.46%

from 2.22B

EPS This Year

8.27

Increased by 27,750.39%

from 0.03

EPS Next Year

9.39

Increased by 13.45%

from 8.27

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	1.32B	2.28B	2.26B	2.38B	2.23B	2.22B	2.32B
Revenue Growth	3.56%	73.21%	-0.92%	5.44%	-6.33%	-0.50%	4.46%
EPS	4.74	-3.11	-1.23	-4.83	0.03	8.27	9.39
EPS Growth	17.91%	-	-	-	-	27,750.39%	13.45%
Forward PE	-	-	-	-	-	15.79	13.92
No. Analysts	-	-	-	-	-	9	9

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028	2029	2030
High	2.3B	2.4B
Avg	2.2B	2.3B
Low	2.1B	2.2B

Revenue Growth

Revenue Growth	2026	2027	2028	2029	2030
High	3.8%	9.1%
Avg	-0.5%	4.5%
Low	-5.3%	-1.1%

EPS Forecast

EPS	2026	2027	2028	2029	2030
High	8.59	10.13
Avg	8.27	9.39
Low	7.89	8.62

EPS Growth

EPS Growth	2026	2027	2028	2029	2030
High	28,812.4%	22.5%
Avg	27,750.4%	13.5%
Low	26,456.0%	4.2%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.